Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
MIMIC: Rapamycin for smoking cessation
NCT04161144Phase 2Completed
- Sponsor
- Medical University of South Carolina
- Start
- Oct 2018
- Primary completion
- Dec 2019
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 2, randomised, double-blind trial in nicotine dependence comparing Rapamycin 15mg (sirolimus) with Placebo (2 arms). Primary endpoints: Craving Levels in Response to Cue at Day 14 and Heart Rate in Response to Cue at Day 14. Started Oct 2018; status: completed.
02
Drugs
sirolimus
03
Conditions
nicotine dependence
Beyond the preview
Go deeper on NCT04161144.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT04161144.